Although many compounds look similar to this compound(7524-52-9)Formula: C12H15ClN2O2, numerous studies have shown that this compound(SMILES:N[C@@H](CC1=CNC2=CC=CC=C12)C(OC)=O.[H]Cl), has unique advantages. If you want to know more about similar compounds, you can read my other articles.
So far, in addition to halogen atoms, other non-metallic atoms can become part of the aromatic heterocycle, and the target ring system is still aromatic.Samsawat, Tipparat; Jaramornburapong, Chanjira; Phutdhawong, Weerachai; Phutdhawong, Waya S.; Taechowisan, Thongchai researched the compound: H-Trp-OMe.HCl( cas:7524-52-9 ).Formula: C12H15ClN2O2.They published the article 《Evaluating the effect of amine-geldanamycin hybrids on anticancer activity》 about this compound( cas:7524-52-9 ) in Journal of Applied Pharmaceutical Science. Keywords: amine geldanamycin hybrid anticancer activity mol docking solubility. We’ll tell you more about this compound (cas:7524-52-9).
Three new geldanamycin (GDM) derivatives, 17-(S)-2-amino-3-(1H-indol-3-ylpropan-1-ol)-17- demethoxygeldanamycin (2), 17-((S)-2-amino-3-phenylpropan-1-ol)-17-demethoxygeldanamycin (3), and 17-((S)-4- (2-amino-3-hydroxypropyl)phenol)-17-demethoxygeldanamycin (4), were synthesized by nucleophilic substitution of GDM (1). The binding ability of these compounds at the N-terminal domain of heat shock protein [Protein Data Bank (PDB) ID: 1OSF] derived from the PDB was analyzed by ligand-protein docking. Hydrogen-bonding interactions of compounds 2 and 3 were equal to those of 17-dimethylamino-ethylamino-17-demethoxygeldanamycin (17-DMAG), with binding energies of -98.33 and -122.41 kcal/mol, resp. The solubility of the synthesized compounds was ascertained. The solubilities of compounds 2, 3, and 4 in water were 5.571 mM, 1.963 mM, and 1.918 mM, higher than that of compound 1 by approx. 36.65, 12.91, and 12.62 times, resp. The cytotoxicity activity of the synthesized compounds was also evaluated against cancer cell lines using a tetrazolium-based colorimetric assay. These compounds showed high anticancer activity against human cervical carcinoma cells cells, with inhibitory concentration (IC50) values in the range of 19.36-45.66 μg/mL, which were better than that of compound 1, with IC50 values of 110.46 μg/mL. Compound 3 also exhibited cytotoxic activity against human hepatocellular carcinoma cells cells, with an IC50 value of 24.62 μg/mL. These compounds were less active against MDA-MB-231 cells, compared with compound 1. Compound 2 also showed weak cytotoxic activity on Vero and LLC-MK2 cells, with IC50 values of 229.19 and 330.58 μg/mL, resp. The predicted results indicated that these compounds have similar absorption, distribution, metabolism, excretion, and toxicity parameters as well as structures predictive of hepatotoxicity. The results showed that some of the synthesized compounds revealed selective cytotoxicity toward some cancer cells. Therefore, further studies on the synthesized compounds could be helpful in the treatment of some cancers.
Although many compounds look similar to this compound(7524-52-9)Formula: C12H15ClN2O2, numerous studies have shown that this compound(SMILES:N[C@@H](CC1=CNC2=CC=CC=C12)C(OC)=O.[H]Cl), has unique advantages. If you want to know more about similar compounds, you can read my other articles.
Reference:
1,3-Benzodioxole – Wikipedia,
Dioxole | C3H4O2 – PubChem